Large deals in H2 2025 included Novartis’ $12 billion acquisition of Avidity Biosciences and Genmab’s buyout of Merus, ...

If you are wondering whether Ascentage Pharma Group International is still a smart bet after its big run, you are not alone, and this piece is going to dig into what the current price really implies.

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their ...

SCHOTT Pharma KGaA's estimated fair value is €21.38 based on 2 Stage Free Cash Flow to Equity Current share price of €18.32 suggests SCHOTT Pharma KGaA is potentially trading close to its fair value ...

We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to ...

As of Friday, December 12, Acumen Pharmaceuticals, Inc.’s ABOS share price has surged by 9.18%, which has investors ...

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) develops and distributes affordable generic and specialty drugs, including key diabetes treatments. Its products include the recently FDA-approved GLP-1 ...